Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (40)
Sirui Zhang, Xiaozhen Zhang, Hanshen Yang, Tingbo Liang & Xueli Bai. (2024) Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879:1, pages 189022.
Crossref
Crossref
Ziyi Zhao, Yingwei Sun, Jing Tang, Yuting Yang & Xiaochao Xu. (2023) LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells. BMC Cancer 23:1.
Crossref
Crossref
Elisa Martella, Barbara Dozza, Claudia Ferroni, Chiara Bellotti, Clement Osuru Obeyok, Matilde Tubertini, Andrea Guerrini, Marco Ballestri, Marta Columbaro, Ilse Manet, Marco Gambarotti, Lucia Martini, Milena Fini, Luca Cevolani, Davide Maria Donati, Enrico Lucarelli, Greta Varchi & Serena Duchi. (2023) Numbers Matter: The Role of Cell Dose in the Treatment of Osteosarcoma Using Mesenchymal Stromal Cells as Cellular Vehicles. Advanced Therapeutics 6:10.
Crossref
Crossref
Carina Proença, Ana Teresa Rufino, Isabela Santos, Hélio M. T. Albuquerque, Artur M. S. Silva, Eduarda Fernandes & José Miguel P. Ferreira de Oliveira. (2023) Gossypetin Is a Novel Modulator of Inflammatory Cytokine Production and a Suppressor of Osteosarcoma Cell Growth. Antioxidants 12:9, pages 1744.
Crossref
Crossref
Camille A. McAloney, Rawan Makkawi, Yogesh Budhathoki, Matthew V. Cannon, Emily M. Franz, Amy C. Gross, Maren Cam, Tatyana A. Vetter, Rebekka Duhen, Alexander E. Davies & Ryan D. Roberts. (2023) Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization. Cellular Oncology.
Crossref
Crossref
Pierre Machy, Erwan Mortier & Stéphane Birklé. (2023) Biology of GD2 ganglioside: implications for cancer immunotherapy. Frontiers in Pharmacology 14.
Crossref
Crossref
Giacomo Milletti, Valeria Colicchia & Francesco Cecconi. (2023) Cyclers’ kinases in cell division: from molecules to cancer therapy. Cell Death & Differentiation.
Crossref
Crossref
Sara R. Martins-Neves, Gabriela Sampaio-Ribeiro & Célia M. F. Gomes. (2023) Self-Renewal and Pluripotency in Osteosarcoma Stem Cells’ Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers. International Journal of Molecular Sciences 24:9, pages 8401.
Crossref
Crossref
Georgina E. Wood, Laurie A. Graves, Elyssa M. Rubin, Damon R. Reed, Richard F. Riedel & Sandra J. Strauss. (2023) Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas. American Society of Clinical Oncology Educational Book:43.
Crossref
Crossref
Shengwen Cheng, Senrui Liu, Bowen Chen, Chengcheng Du, Pengcheng Xiao, Xuefeng Luo, Li Wei, Yiting Lei, Chen Zhao & Wei Huang. (2023) Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways. Chinese Medicine 18:1.
Crossref
Crossref
Huichao Fu, Yunjiao Wu, Jianbai Chen, Xing Hu, Xiaoyan Wang & Gongping Xu. (2023) Exosomes and osteosarcoma drug resistance. Frontiers in Oncology 13.
Crossref
Crossref
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Craig A. Hokanson, Francesco Conforti, Nicoletta Staropoli, Luigia Gervasi, Maria Teresa Di Martino, Mariamena Arbitrio, Giuseppe Nisticò, Roberto Crea, Pierosandro Tagliaferri, Giada Juli & Pierfrancesco Tassone. (2023) The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas. Cancers 15:6, pages 1647.
Crossref
Crossref
Edgar Yebrán Villegas-Vázquez, Laura Itzel Quintas-Granados, Hernán Cortés, Manuel González-Del Carmen, Gerardo Leyva-Gómez, Miguel Rodríguez-Morales, Lilia Patricia Bustamante-Montes, Daniela Silva-Adaya, Carlos Pérez-Plasencia, Nadia Jacobo-Herrera, Octavio Daniel Reyes-Hernández & Gabriela Figueroa-González. (2023) Lithium: A Promising Anticancer Agent. Life 13:2, pages 537.
Crossref
Crossref
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti & Massimo Serra. (2023) Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences 24:1, pages 799.
Crossref
Crossref
Goran J. Djuričić, Helmut Ahammer, Stanislav Rajković, Jelena Djokić Kovač, Zorica Milošević, Jelena P. Sopta & Marko Radulovic. (2022) Directionally Sensitive Fractal Radiomics Compatible With Irregularly Shaped Magnetic Resonance Tumor Regions of Interest: Association With Osteosarcoma Chemoresistance. Journal of Magnetic Resonance Imaging 57:1, pages 248-258.
Crossref
Crossref
Natalia Todosenko, Kristina Yurova, Olga Khaziakhmatova, Vladimir Malashchenko, Igor Khlusov & Larisa Litvinova. (2022) Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells. Pharmaceutics 14:10, pages 2181.
Crossref
Crossref
Duoli Xie, Zhuqian Wang, Jie Li, De-an Guo, Aiping Lu & Chao Liang. (2022) Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment. Frontiers in Oncology 12.
Crossref
Crossref
Ann Neiheisel, Manpreet Kaur, Nancy Ma, Patty Havard & Anitha K. Shenoy. (2021) Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials. International Journal of Cancer 150:5, pages 727-740.
Crossref
Crossref
Heidi M. Namløs, Magne Skårn, Deeqa Ahmed, Iwona Grad, Kim Andresen, Stine H. Kresse, Else Munthe, Massimo Serra, Katia Scotlandi, Antonio Llombart-Bosch, Ola Myklebost, Guro E. Lind & Leonardo A. Meza-Zepeda. (2022) miR-486-5p expression is regulated by DNA methylation in osteosarcoma. BMC Genomics 23:1.
Crossref
Crossref
Nora Berois, Alvaro Pittini & Eduardo Osinaga. (2022) Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. Cancers 14:3, pages 645.
Crossref
Crossref
Yuping Wang, Jin Chen, Yanran Huang, Shengdong Yang, Tao Tan, Nan Wang, Jun Zhang, Caihong Ye, Mengqi Wei, Jinyong Luo & Xiaoji Luo. (2022)
Schisandrin B suppresses osteosarcoma lung metastasis
in vivo
by inhibiting the activation of the Wnt/β‑catenin and PI3K/Akt signaling pathways
. Oncology Reports 47:3.
Crossref
Crossref
Xin Hu, Yang Wen, Lin-yun Tan, Jie Wang, Fan Tang, Yi-tian Wang, Chuan-xi Zheng, Yu-qi Zhang, Tao-jun Gong & Li Min. (2022) Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma. Frontiers in Oncology 11.
Crossref
Crossref
Steven L. Wood, Ana Lopez-Guajardo & Janet E. Brown. 2022. Bone Cancer. Bone Cancer
783
803
.
Mateja Mikulčić, Nassim Ghaffari Tabrizi-Wizsy, Eva M. Bernhart, Martin Asslaber, Christopher Trummer, Werner Windischhofer, Wolfgang Sattler, Ernst Malle & Andelko Hrzenjak. (2021) 15d-PGJ2 Promotes ROS-Dependent Activation of MAPK-Induced Early Apoptosis in Osteosarcoma Cell In Vitro and in an Ex Ovo CAM Assay. International Journal of Molecular Sciences 22:21, pages 11760.
Crossref
Crossref
Cátia F. Monteiro, Catarina A. Custódio & João F. Mano. (2021) Bioengineering a humanized 3D tri-culture osteosarcoma model to assess tumor invasiveness and therapy response. Acta Biomaterialia 134, pages 204-214.
Crossref
Crossref
Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, Giordano Nicoletti, Patrizia Nanni & Pier-Luigi Lollini. (2021) HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy. Cells 10:7, pages 1808.
Crossref
Crossref
Claudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, Chiara Casotti, Chiara Riganti & Massimo Serra. (2021) Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers 13:12, pages 2878.
Crossref
Crossref
Zhinan Ren, Jun Li, Shanwen Zhao, Qi Qiao & Runguang Li. (2021) Knockdown of MCM8 functions as a strategy to inhibit the development and progression of osteosarcoma through regulating CTGF. Cell Death & Disease 12:4.
Crossref
Crossref
Shilpi Agrawal, Sanhita Maity, Zeina AlRaawi, Musaab Al-Ameer & Thallapuranam Krishnaswamy Suresh Kumar. (2021) Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling. Current Drug Targets 22:2, pages 214-240.
Crossref
Crossref
Yuan Gao, Lunhao Bai & Guanning Shang. (2020) Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20. Aging 13:2, pages 2668-2680.
Crossref
Crossref
Hangzhan Ma, Dylan C. Dean, Ran Wei, Francis J. Hornicek & Zhenfeng Duan. (2021) Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2199506.
Crossref
Crossref
Yi Zhang, Antonio Solinas, Stefano Cairo, Matthias Evert, Xin Chen & Diego F. Calvisi. (2021) Molecular Mechanisms of Hepatoblastoma. Seminars in Liver Disease 41:01, pages 028-041.
Crossref
Crossref
Piamsiri Sawaisorn, Korakot Atjanasuppat, Usanarat Anurathapan, Somchai Chutipongtanate & Suradej Hongeng. (2020) Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma. Vaccines 8:4, pages 753.
Crossref
Crossref
Juncheng Cui, Dylan Dean, Ran Wei, Francis J. Hornicek, David Ulmert & Zhenfeng Duan. (2020) Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma. Journal of Orthopaedic Research 38:11, pages 2362-2372.
Crossref
Crossref
Ingrid Lilienthal & Nikolas Herold. (2020) Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. International Journal of Molecular Sciences 21:18, pages 6885.
Crossref
Crossref
Niels Schaft. (2020) The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview. Cancers 12:9, pages 2567.
Crossref
Crossref
Carlos Rodríguez-Nogales, Haritz Moreno, Carolina Zandueta, Didier Desmaële, Fernando Lecanda, Patrick Couvreur & María J. Blanco-Prieto. (2020) Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma. Cancers 12:7, pages 1895.
Crossref
Crossref
Martina Godel, Deborah Morena, Preeta Ananthanarayanan, Ilaria Buondonno, Giulio Ferrero, Claudia M. Hattinger, Federica Di Nicolantonio, Massimo Serra, Riccardo Taulli, Francesca Cordero, Chiara Riganti & Joanna Kopecka. (2020) Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma. International Journal of Molecular Sciences 21:12, pages 4500.
Crossref
Crossref
Katia Scotlandi, Claudia Maria Hattinger, Evelin Pellegrini, Marco Gambarotti & Massimo Serra. (2020) Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors. Cells 9:4, pages 968.
Crossref
Crossref
Dimas Carolina Belisario, Muhlis Akman, Martina Godel, Virginia Campani, Maria Pia Patrizio, Lorena Scotti, Claudia Maria Hattinger, Giuseppe De Rosa, Massimo Donadelli, Massimo Serra, Joanna Kopecka & Chiara Riganti. (2020) ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 9:3, pages 647.
Crossref
Crossref